Presenters from AAOpt26's research symposium share their findings, applications for optometric practice, and goals for future study.
|Videos|June 17, 2022
Alzheimer's disease and optometry: diagnosis, prevention, management
Stuart Richer, OD, PhD, provides an overview of his AOA 2022 presentation titled, "Alzheimer's disease: diagnostic criteria, prevention, and lifestyle management."
Advertisement
Optometry Times®' Alex Delaney-Gesing speaks with Stuart Richer, OD, PhD, director of ocular preventative medicine at Captain James Lovell Federall Health Care Facility in Chicago, Illinois, who provides an overview of his presentation titled, "Alzheimer's disease: diagnostic criteria, prevention, and lifestyle management" during the 2022 American Optometric Association (AOA) meeting in Chicago.
Advertisement
Related to this article
Walline, American Academy of Optometry president, shares this year's conference attendance numbers, clinical pearls, and what he hopes to see in 2027.
Thomas Wong, OD, FAAO, details a session he presented alongside Ronald Gentile, MD, FACS, FASRS, at AAOpt 2026.
Kevin Chan, OD, MS, discusses an AAOpt 2026 symposium on individualized low-dose atropine dosing for myopia and the FDA outlook ahead of the SYD-101 advisory meeting.
Raman Bhakhri, OD, FAAO, alongside Xiao Yu, OD, FAAO, discussed emerging investigational therapies for the disease during their AAOpt 2026 session.
Jamie Kuzniar, OD, FAAO, FSLS, discusses a case-based AAOpt 2026 session on scleral lens complications, fitting around cross-linking, and advice for new graduates.
Kwaku Osei, OD, PhD, FAAO, discussed patient-reported outcomes with a senofilcon C (Johnson & Johnson; Acuvue Vita), reusable lens, with the majority of wearers rating comfort, vision, and handling favorably.
Andrew Pucker, OD, PhD, FAAO, FSLS, FBCLA, discussed how oculomics research presented at AAOpt 2026 could eventually support point-of-care diagnosis and referral decisions.
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
AAOpt 2026: Current controversies in macular hole diagnosis, management
2
FDA approves phentolamine ophthalmic solution 0.75% (Ryzumvi) for presbyopia
3
FDA approves subcutaneous Enspryng for TED
4
2026 Nobel Prize in Physiology or Medicine awarded for optogenetics discovery
5